查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790292

細胞和基因療法臨床試驗市場規模、佔有率和趨勢分析報告：按階段、適應症、地區和細分市場預測，2025 年至 2033 年

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

細胞與基因治療臨床試驗市場摘要

市場的主要驅動力在於基因醫學技術創新的加速以及對先進療法監管支持的不斷加強。 CRISPR 等基因組編輯技術的進展，以及病毒和非病毒載體遞送系統的突破，使研究人員能夠開發針對罕見遺傳疾病、癌症和自體免疫疾病的高度標靶化候選治療藥物。 FDA 和 EMA 等監管機構推出了加速核准途徑、孤兒藥資格認定和再生醫學先進療法 (RMAT) 資格認定，以支持 CGT 的開發。這些激勵措施顯著減輕了開發新型 CGT 產品的公司的時間和成本負擔，並鼓勵進行早期試驗。

此外，資本的湧入以及專注於CGT開發的生物技術公司、大型製藥公司和學術研究中心之間的策略聯盟正在推動市場發展。這種資金勢頭，尤其是來自創業投資和公私合營關係的資金，使臨床試驗申辦方能夠從初步試驗擴展到多中心國際試驗。 Bluebird Bio、CRISPR Therapeutics和Beam Therapeutics等公司已在鐮狀細胞疾病、CAR-T療法和基於基因編輯的腫瘤學研發管線等領域啟動了多項I/II期試驗。此外，檢驗這些治療方法的安全性、劑量和長期療效的需求，也推動了對專門的CRO和針對CGT試驗的測試基礎設施的需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章細胞和基因治療臨床試驗市場：變數、趨勢和範圍

  • 市場體系展望
  • 細胞與基因治療臨床試驗市場動態
  • 技術格局
  • 定價模式分析
  • 細胞與基因治療臨床試驗市場：分析工具

第4章：細胞和基因治療臨床試驗市場：各階段的估計和趨勢分析

  • 細分儀表板
  • 全球細胞和基因治療臨床試驗市場分階段波動分析
  • 全球細胞基因治療臨床試驗市場規模及趨勢分析（分階段，2021-2033）
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第5章：細胞和基因治療臨床試驗市場：按適應症的估計和趨勢分析

  • 細分儀表板
  • 全球細胞和基因治療臨床試驗市場按適應症波動分析
  • 全球細胞和基因療法臨床試驗市場規模和趨勢分析（按適應症，2021-2033 年）
  • 腫瘤學
  • 心臟病學
  • 中樞神經系統
  • 肌肉骨骼
  • 感染疾病
  • 皮膚科
  • 內分泌學、代謝和遺傳學
  • 免疫學和炎症
  • 眼科
  • 血液學
  • 胃腸病學
  • 其他

6. 細胞和基因療法臨床試驗市場：按類型、產品、測試、樣本和最終用途的區域估計和趨勢分析

  • 區域市場儀表板
  • 全球區域市場概況
  • 市場規模、預測趨勢分析，2021-2033年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 公司分類
  • 細胞與基因治療臨床試驗市場佔有率分析（2024年）
  • 公司簡介
    • IQVIA
    • ICON Plc
    • LabCorp
    • Charles River Laboratories
    • PAREXEL International Corp.
    • Syneos Health
    • Medpace
    • Thermo Fisher Scientific, Inc.
    • Novotech
    • Veristat, LLC
Product Code: GVR-4-68039-409-7

Cell And Gene Therapy Clinical Trials Market Summary

The market is primarily driven by the accelerating pace of innovation in genetic medicine and increasing regulatory support for advanced therapies. Advancements in genome editing technologies such as CRISPR, as well as breakthroughs in viral and non-viral vector delivery systems, have enabled researchers to develop highly targeted therapeutic candidates for rare genetic disorders, cancers, and autoimmune diseases. Regulatory bodies, including the FDA and EMA, have introduced accelerated approval pathways, orphan drug designations, and RMAT (Regenerative Medicine Advanced Therapy) designations to support CGT development. These incentives have significantly reduced the time and cost burden for companies developing novel CGT products, encouraging the launch of early-phase trials.

Furthermore, the influx of funding and strategic partnerships between biotech firms, large pharmaceutical companies, and academic research centers focused on CGT development is driving the market growth. This financial momentum, especially from venture capital and public-private collaborations, is enabling clinical trial sponsors to scale up from pilot studies to multi-site international trials. Companies like Bluebird Bio, CRISPR Therapeutics, and Beam Therapeutics, numerous Phase I/II trials are being initiated in areas such as sickle cell disease, CAR-T therapies, and gene editing-based oncology pipelines.Moreover, the need to validate safety, dosing, and long-term efficacy of these therapies has increased demand for specialized CROs and trial infrastructure tailored to CGT studies.

Global Cell And Gene Therapy Clinical Trials Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell and gene therapy clinical trials market report based on phase, indication, and region:

  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiology
  • CNS
  • Musculoskeletal
  • Infectious diseases
  • Dermatology
  • Endocrine, metabolic, genetic
  • Immunology & inflammation
  • Ophthalmology
  • Hematology
  • Gastroenterology
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell And Gene Therapy Clinical Trials Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Cell And Gene Therapy Clinical Trials Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
      • 3.2.1.1. Growing Interest in Cell and Gene Therapy
      • 3.2.1.2. Adoption Of New Technology in Clinical Research
      • 3.2.1.3. Increasing Investments And R&D Funding
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Recruitment Obstacles
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Cell And Gene Therapy Clinical Trials Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Cell And Gene Therapy Clinical Trials Market: Phase Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell and Gene Therapy Clinical Trials Market Phase Movement Analysis
  • 4.3. Global Cell and Gene Therapy Clinical Trials Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cell And Gene Therapy Clinical Trials Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell and Gene Therapy Clinical Trials Market Indication Movement Analysis
  • 5.3. Global Cell and Gene Therapy Clinical Trials Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiology
    • 5.5.1. Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. CNS
    • 5.6.1. CNS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Musculoskeletal
    • 5.7.1. Musculoskeletal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Infectious diseases
    • 5.8.1. Infectious diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Dermatology
    • 5.9.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Endocrine, metabolic, genetic
    • 5.10.1. Endocrine, metabolic, genetic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Immunology & inflammation
    • 5.11.1. Immunology & inflammation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Ophthalmology
    • 5.12.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.13. Hematology
    • 5.13.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.14. Gastroenterology
    • 5.14.1. Gastroenterology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.15. Others
    • 5.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cell And Gene Therapy Clinical Trials Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Cell And Gene Therapy Clinical Trials Market Share Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. IQVIA
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. ICON Plc
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. LabCorp
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Charles River Laboratories
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. PAREXEL International Corp.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Syneos Health
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Medpace
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Thermo Fisher Scientific, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Novotech
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Veristat, LLC
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 4 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 5 U.S. Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 6 U.S. Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 7 Canada Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 8 Canada Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 9 Mexico Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 10 Mexico Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 11 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 12 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 13 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 14 UK Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 15 UK Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 16 Germany Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 17 Germany Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 18 France Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 19 France Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 20 Italy Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 21 Italy Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 22 Spain Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 23 Spain Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 24 Norway Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 25 Norway Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 26 Denmark Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 27 Denmark Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 28 Sweden Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 29 Sweden Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 31 Japan Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 32 Japan Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 33 China Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 34 China Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 35 India Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 36 India Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 37 Australia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 38 Australia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 39 South Korea Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 40 South Korea Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 41 Thailand Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 42 Thailand Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 43 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 45 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 46 Brazil Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 47 Brazil Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 48 Argentina Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 49 Argentina Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 50 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 51 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 52 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 53 South Africa Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 54 South Africa Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 55 Saudi Arabia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 56 Saudi Arabia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 57 Kuwait Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 58 Kuwait Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 59 UAE Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 60 UAE Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Cell And Gene Therapy Clinical Trials market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Cell And Gene Therapy Clinical Trials market dynamics
  • Fig. 19 Total R&D drug pipeline size, 2021 - 2024
  • Fig. 20 Total drug pipeline by development phase, 2024
  • Fig. 21 Porter's five forces analysis
  • Fig. 22 PESTEL analysis
  • Fig. 23 Cell And Gene Therapy Clinical Trials market phase outlook: Segment dashboard
  • Fig. 24 Cell And Gene Therapy Clinical Trials market, by phase segment: Market share, 2025 & 2033
  • Fig. 25 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Cell And Gene Therapy Clinical Trials market indication outlook: Segment dashboard
  • Fig. 30 Cell And Gene Therapy Clinical Trials market, by indication segment: Market share, 2024 & 2033
  • Fig. 31 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Cardiology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 CNS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Musculoskeletal market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Dermatology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Endocrine, metabolic, genetic market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Immunology & inflammation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Hematology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Gastroenterology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Regional market: Key takeaways
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 U S Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Mexico Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 France Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Italy Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Denmark Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Japan Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 China Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 India Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Argentina Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Kuwait Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Market participant categorization
  • Fig. 97 Heat map analysis